
REDMILE GROUP, LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | ADCT | 15.67M | $62.67M |
![]() | FATE | 12.87M | $16.22M |
![]() | ABSI | 8.25M | $25.09M |
![]() | ANNX | 6.30M | $19.22M |
![]() | STTK | 5.54M | $13.24M |
![]() | IMNM | 5.02M | $58.82M |
![]() | RGNX | 4.69M | $45.29M |
![]() | STOK | 4.18M | $98.13M |
![]() | SRRK | 3.90M | $145.40M |
![]() | ZYME | 3.71M | $63.29M |
![]() | NRIX | 3.68M | $33.99M |
![]() | ALXO | 3.33M | $6.10M |
![]() | NUVB | 3.03M | $11.21M |
![]() | IVVD | 2.29M | $2.51M |
![]() | COGT | 2.21M | $31.72M |
![]() | SLN | 2.16M | $11.24M |
![]() | LVTX | 2.07M | $3.24M |
![]() | SLDB | 1.90M | $11.72M |
![]() | PLRX | 1.59M | $2.36M |
![]() | RPTX | 1.59M | $2.79M |

ADC Therapeutics S.A.
ADCT
Shares Held
15.67M
Value
$62.67M

Fate Therapeutics, Inc.
FATE
Shares Held
12.87M
Value
$16.22M

Absci Corporation
ABSI
Shares Held
8.25M
Value
$25.09M

Annexon, Inc.
ANNX
Shares Held
6.30M
Value
$19.22M

Shattuck Labs, Inc.
STTK
Shares Held
5.54M
Value
$13.24M

Immunome, Inc.
IMNM
Shares Held
5.02M
Value
$58.82M

REGENXBIO Inc.
RGNX
Shares Held
4.69M
Value
$45.29M

Stoke Therapeutics, Inc.
STOK
Shares Held
4.18M
Value
$98.13M

Scholar Rock Holding Corporation
SRRK
Shares Held
3.90M
Value
$145.40M

Zymeworks Inc.
ZYME
Shares Held
3.71M
Value
$63.29M

Nurix Therapeutics, Inc.
NRIX
Shares Held
3.68M
Value
$33.99M

ALX Oncology Holdings Inc.
ALXO
Shares Held
3.33M
Value
$6.10M

Nuvation Bio Inc.
NUVB
Shares Held
3.03M
Value
$11.21M

Invivyd, Inc.
IVVD
Shares Held
2.29M
Value
$2.51M

Cogent Biosciences, Inc.
COGT
Shares Held
2.21M
Value
$31.72M

Silence Therapeutics plc
SLN
Shares Held
2.16M
Value
$11.24M

LAVA Therapeutics N.V.
LVTX
Shares Held
2.07M
Value
$3.24M

Solid Biosciences Inc.
SLDB
Shares Held
1.90M
Value
$11.72M

Pliant Therapeutics, Inc.
PLRX
Shares Held
1.59M
Value
$2.36M

Repare Therapeutics Inc.
RPTX
Shares Held
1.59M
Value
$2.79M
